BLTE Q4 2024 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena

BLTEBelite Bio, Inc

$7B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$11M

Net Income

-$10M

EPS (Diluted)

$-0.32

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$8,987

Balance Sheet

Total Assets

$152M

Total Liabilities

$6M

Stockholders' Equity

$146M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$11M	-$7M	-64.7%
Net Income	-$10M	-$7M	-44.5%